Neonatal and Child Health
At Maternova, we focus on neonatal health because of the vulnerability of newborns during this period (0-28 days of life) and the existence of simple, proven innovations that can improve the odds of life and well-being of the child during this critical period.
According to the World Health Organization, 44 percent of child mortality is attributable to the neonatal period.
Dramatic progress is possible, with the technology we already have–globally, the number of neonatal deaths declined from 5.0 million in 1990 to 2.3 million in 2022. The leading causes of death (and morbidity) today are premature birth, birth complications (birth asphyxia/trauma), neonatal infections and congenital anomalies
We source and distribute the BiliDx, a bilirubinometer that detects jaundice at the point of care, the DreamWarmer infant heating mattress to prevent hypothermia and the Pumani Bubble CPAP, a rugged, proven device to treat respiratory distress.
Our solutions include the Pratt Pouch - a drug delivery device that provides each mother with a pre-filled dose of antiretrovirals for her child. The team continuously talks with innovators in the neonatal (and child) space, seeking evidence-based, clinically-relevant devices, diagnostics and drug delivery systems for children and neonates.